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Abstract: 
Background: Life stresses and negative emotions, such as anxiety and depression, are associated 
with adverse cardiac events, including arrhythmia. Patients undergoing implantation of an 
automatic internal cardioverter defibrillator provide a unique opportunity to characterize these 
relationships since all tachyarrhythmia episodes are recorded by the device. 
 
Objectives: The purpose of this study was to examine the association of emotional status after 
internal cardioverter defibrillator (ICD) implantation and subsequent arrhythmia events. 
 
Methods: An analysis of data obtained in a prospective longitudinal study of responses to the 
ICD measured mood disturbance (Profile of Mood States; POMS) before implant and at 1, 3, 6, 
and 9 months postoperatively. Subjects included 144 men and 32 women with a mean age of 60 
± 13 years and a mean left ventricular ejection fraction (LVEF) of 33± 12%. Arrhythmia events 
were measured by self-report of shocks and by ICD device interrogation to obtain the number 
and type (defibrillation, cardioversion, and antitachycardia pacing) of therapies delivered by the 
ICD. For each time point, POMS scores of subjects who had arrhythmia events were compared 
with those who did not. For subjects who had ICD shocks, pre-event and post-event POMS 
scores were also compared. Multiple logistic regression was used at each time point to determine 
if clinical, demographic and psychological data could predict arrhythmia events. 
 
Results: Patients with arrhythmia events had higher POMS scores throughout the 9 months of 
follow-up. Higher level of mood disturbance (specifically anxiety, fatigue, and confusion) at 1 
and 3 months were independent predictors of subsequent arrhythmia events at 3 and 6 months 
after controlling for LVEF, the presence of coronary artery disease, pre-implant arrhythmia 
history, and the use of amiodarone and beta-blocking agents. There were no differences in 
POMS scores before and after ICD shocks, reinforcing the notion that negative emotions were a 
cause, rather than a consequence, of arrhythmia events. 
anxiety | ventricular arrhythmia | implanted cardioverter defibrillator | mood Keywords: 
disturbance | depression 
Article: 
INTRODUCTION 
More than 250,000 persons in the United States succumb to sudden cardiac death annually, 
usually as the result of ventricular tachycardia and ventricular fibrillation [Myerburg and 
Demirovic, 1995; American Heart Association, 1998]. Even if they are rescued, these patients 
have a high incidence of recurrent arrest. The implanted cardioverter defibrillator (ICD) has 
become the standard of care for these patients and also has been shown to prolong life when used 
in asymptomatic patients at high risk for malignant ventricular arrhythmias [Moss et al., 1996; 
AVID Investigators, 1997; Owens et al., 1997]. The ICD automatically detects and terminates 
tachyarrhythmias by using overdrive pacing or high-voltage shocks. In addition, the device stores 
both R-R intervals and intracardiac electrograms whenever tachyarrhythmia is detected. 
Interrogation of the ICD with an external programmer allows retrieval of these data at the time of 
the next follow-up visit. 
Psychosocial studies of ICD patients reveal fairly high acceptance of the device by patients and 
families [Sneed and Finch, 1992; Luderitz et al., 1993, 1994; Pycha et al., 1986, 1990]. However, 
varying degrees of psychological distress have been recorded with 15–50% of ICD patients 
experiencing such responses as anxiety, anger, depression and withdrawal [Fricchione et al., 
1989; Vlay et al., 1989; Keren et al., 1991; Morris et al., 1991]. These responses are attributed to 
feelings of vulnerability [Kuiper and Nyamathi, 1991; Burke et al., 1992; Sneed and Finch, 
1992], lifestyle changes such as restricted driving [Finch et al., 1997], and experiences related to 
device discharge [Dougherty, 1995; Dunbar et al., 1993]. 
Psychological states as precursors to arrhythmia have been suspected for some time [Lown et al., 
1980]. In the cardiac arrhythmia suppression trial (CAST-I), level of perceived social support 
was a predictor of mortality after myocardial infarction [Gorkin et al., 1993]. In a subset of 
patients studied within the GUSTO trial, anxiety measured in the first 48 hr after myocardial 
infarction was associated with subsequent in-hospital ischemia, sustained ventricular tachycardia 
and ventricular fibrillation [Moser and Dracup, 1996]. Intense, unexpected stimuli, such as 
earthquakes, are followed by an increased incidence of sudden death and ICD activity [Leur and 
Loner, 1995; Nishimoto et al., 1995]. 
To determine whether emotional state was related to subsequent arrhythmia events in patients at 
high risk for recurrent ventricular arrhythmia, we performed a secondary analysis using data 
from a prospective study in which we originally followed ICD patients over the first 9 months 
after implantation [Dunbar, 1996]. The aim of this analysis was to examine the relationships 
between emotional states and arrhythmia events and ICD activations and whether subsequent 
arrhythmia events in the early recovery phase after ICD implantaion could be determined from 
emotional and clinical variables.  
METHODS 
SUBJECTS 
Subjects for this analysis were drawn from a sample participating in a repeated measures, 
longitudinal study of coping, emotional, and functional outcomes in the first 9 months after ICD 
insertion [Dunbar, 1996]. Patients were eligible if they were receiving their initial ICD, had 
intact memory and cognitive function, could read and write English, and had no history of 
psychiatric illness requiring medication, psychotherapy, or hospitalization. The study protocol 
was approved by the Human Research Committee at Emory University and all subjects provided 
written consent. In the primary study, subjects (n=213) were men (83%) and women (17%) who 
received an initial ICD for treatment of ventricular arrhythmia at five participating hospitals in 
the southeastern and Midwestern United States. Ages ranged from 24–85 years with a mean age 
of 59 ± 13 years. Twenty-three percent had been resuscitated from cardiac arrest; 14% were 
taking amiodarone, and 18% were receiving beta adrenergic blockers at the time of enrollment. 
Most subjects were married (79%) and well educated, with 42% having completed some post-
secondary education. All subjects who completed 9 months of follow-up and had data suitable 
for analysis were included in the current study.  
Demographic and clinical variables for the primary and secondary samples are presented in 
Table 1. No differences were found, suggesting that the subset who completed the study were 
comparable to the cohort as a whole. 
PROCEDURES AND MEASURES 
Prior to receiving the ICD, subjects completed a battery of questionnaires selected to measure 
emotional status, functional status, perceptions of illness, and concerns. These instruments were 
completed again at 1, 3, 6, and 9 months after ICD implant [Dunbar et al., 1996; Dunbar et al., 
1997; Dunbar et al., 1999]. Emotional status was measured by the Profile of Mood States 
(POMS) [McNair et al., 1993], which includes 65 adjectives that subjects rate on a five-point 
scale according to how well each adjective describes their feelings during the past week. Six 
emotional dimensions, including tension-anxiety, depression-dejection, anger-hostility, vigor-
activity, fatigue-inertia, and confusion-bewilderment are measured. Total Mood Disturbance 
(TMD) is measured by summing the six primary mood scores with vigor weighted negatively. 
Internal consistency for the six scales ranges from 0.84 to 0.95 in a normative population 
[McNair et al., 1993] and from 0.84-0.97 in this sample. 
Subjects also completed and returned a device activation form [Dunbar et al., 1993] within 24 hr 
of receiving a shock from the ICD. These forms were used to track perceived shocks and to 
compare with results of ICD interrogation. Device interrogation provided precise information 
regarding the date and time of the arrhythmia and the type of therapy delivered. Subjects were 
considered to have had an arrhythmia event if antitachycardia pacing, cardioversion, or 
defibrillation had been delivered by the ICD during the follow-up time period. 
Table 1 has been omitted from this formatted document. 
STATISTICAL ANALYSIS 
All data were analyzed using the Statistical Package for Social Science (SPSS v.7.0). Subjects 
were divided into two groups (no arrhythmia events and arrhythmia events) at each follow-up 
time point according to whether or not they had received ICD therapy (antitachycardia pacing, 
cardioversion, or defibrillation). Demographic, clinical, and POMS subscale data were compared 
by group using chi square and Student’s ttest for unpaired variables. To determine the influence 
of ICD shocks on emotional state, TMD scores before the first arrhythmia event were compared 
with TMD scores at the next follow-up visit using Student’s t-test for paired data. 
At each time point of 0, 1, 3, 6, and 9 months after ICD insertion, separate multiple logistic 
regression analyses were used to determine if emotional state (independent variable) could be 
used to predict the occurrence of an arrhythmia event (dependent variable) while controlling for 
selected clinical and demographic variables. Due to the wide range of possible scores on the 
POMS, the scaling of the TMD scores was converted into increments of 10. By using stepwise 
multiple logistic regression, the following variables were entered first as a block: history of 
cardiac arrest, history of coronary artery disease, left ventricular ejection fraction, and treatment 
with amiodarone or beta-adrenergic blocking drugs. The TMD score from the prior follow-up 
time point was then entered into the equation as the second step. Additional analyses occurred 
with each POMS subscale replacing the TMD score in separate logistic regression equations. 
Alpha was set at P£.05. 
RESULTS 
Of the 213 patients entering the study, 176 had data suitable for the analysis. Thirty-five subjects 
had an arrhythmia event by the 1 month follow-up period with 35, 32, and 23 experiencing 
events at the 3, 6, and 9 month periods, respectively. Thirty-one subjects had arrhythmia events 
in more than 1 time frame. There were no differences in the demographic or clinical 
characteristics between subjects who had arrhythmic events during follow-up as compared with 
those who did not (Table 1). In contrast, TMD scores were consistently higher in the cohort with 
arrhythmia events at 1, 3, 6, and 9 month follow-up compared with those who were arrhythmia-
free (Fig. 1). 
Multiple logistic regression revealed that baseline TMD score did not predict arrhythmia event 
groups at 1 month. However, significant models were found for 3 and 6 month analyses. The 1 
month TMD score was the only independent predictor of an arrhythmia event by the time of the 
3 month follow-up (odds ratio 1.16, 95% CI 1.03 to 1.32, P=.01) (see Table 2). To determine 
specific effects of emotional status on arrhythmia events, subscale scores of anxiety, depression, 
anger, fatigue, confusion, and vigor were substituted for TMD in separate logistical regression 
analyses. Significant models were found when the emotional status variables were anxiety (odds 
ratio 1.07, 95% CI 1.01–1.13, P=.03), fatigue (odds ratio 1.10, 95% CI 1.03–1.17, P=.003), vigor 
(odds ratio .91, 95% CI .84–.98, P=.01), or confusion (odds ratio 1.13, 95%CI 1.04–1.25, 
P=.006). The relationships for total mood disturbance and subscale scores were such that the 
greater the score or presence of the emotional state, the greater the likelihood of arrhythmia 
events with vigor negatively weighted. 
Figure 1 and Tables 2 & 3 are omitted from this formatted document. 
Similarly, only the 3 month TMD score (OR=1.14, 95% CI 1.03–1.30, P=.04) was an 
independent predictor of arrhythmia events between 3 and 6 months (see Table 3). Similar to the 
three month predictive models, separate significant subscale models included anxiety (OR 1.07, 
95% CI 1.01–1.14, P=.02), fatigue (OR 1.07 95% CI .99–1.15, P=.05), vigor (OR .90, 95% CI 
.84–.97, P=.002), and confusion (OR 1.14, 95% CI 1.02–1.26, P=.01). Neither anger nor 
depression were significant predictors at either the 3 or 6 month follow-up time points. For the 
6–9 month follow up period, no significant predictors were found. 
Although mood disturbance appeared to predict arrhythmia events, the converse was not true. 
Paired ttest revealed there was no difference in the POMS scores obtained at the follow-up visit 
before and just after an ICD shock (mean values = 26.3 vs 26.8; t =.143, P=.89). This was also 
the case if only the POMS scores before and after the first shock were considered for those 
subjects with more than one arrhythmia event. 
DISCUSSION 
Prospective evaluation of patients receiving devices for management of malignant ventricular 
arrhythmias revealed that the best predictor of arrhythmia events after ICD insertion was the 
emotional status of the patient at the prior follow-up visit. The greater the total mood 
disturbance, the greater the likelihood of experiencing an arrhythmia event that required 
antitachycardia pacing, cardioversion, or defibrillation by the ICD. Odds ratios suggested that for 
each tenpoint increase in TMD, the chance of arrhythmia increased by 10–20%. More 
specifically, the greater the anxiety, fatigue, and confusion subscale scores and the lower the 
vigor score at 1 and 3 months, the greater the likelihood of experiencing an arrhythmic event at 3 
and 6 months. These findings are particularly compelling given the stepwise logistic regression 
approach which revealed the independent influence of mood after controlling for traditional 
arrhythmia risk factors of previous history of cardiac arrest, history of coronary artery disease, 
and poor LVEF [Furukawa et al., 1989; Myerburg and Demirovic, 1995]. 
Mood disturbance at the initial baseline assessment before ICD implant did not predict 
occurrence of arrhythmia events by the 1 or 3 month follow-up visit. This may be due to the 
multitude of possible, intervening variables that influence both the development of mood 
disturbance and the relationship between mood disturbance measured in the acute care setting 
and outcome during the early postoperative period. For example, the mood disturbance measured 
at baseline in the acute care setting reflects a more transient response to change in illness status 
and treatment options. Experiences occurring during the inpatient setting and early recovery 
period included learning about their high risk status and need for an ICD, therapeutic procedures 
such as electrophysiology studies, changes in antiarrhythmic medication doses, and device 
reprogramming after implantation, all of which could have influenced the relationship between 
baseline assessment and arrhythmia event. This study demonstrates the need for ongoing 
evaluation of emotional response to living with a highrisk arrhythmia and its treatment with the 
ICD. The distance from implant time, variation in emotional adaptation, and device 
reprogamming may have artificially attenuated the lack of influence of mood factors at nine 
months. 
Dougherty et al. [1995] found that subjects who received shocks in the first year after ICD 
implantation had more anxiety, depression, and anger than patients who had not received shocks. 
Similarly, Keren and coworkers [1991] noted greater distress among patients who had 
experienced five or more shocks in the first year after implant. These findings are comparable to 
the observations made in the current study, in which the arrhythmia group had significantly 
higher degrees of mood disturbance than those who remained arrhythmia free during the 9 
months of follow-up. The previous reports assumed that shocks were a cause of emotional 
distress. Results of the current study suggest that mood disturbance may, in fact, preceed 
arrhythmia events and that ICD shocks appear to have relatively little impact on overall mood 
disturbance. Differences in our findings and those of Doughtery and Keren may be due to 
improved standards of care over time and increased preparation of patients regarding what to 
expect with device therapy. 
A number of studies have documented an association between emotion, stress, and adverse 
cardiac events. Several hypothesized mechanisms or pathways are suggested including 
neuroendocrine activation, myocardial ischemia, and platelet dysfunction. Mental stress and 
anger have a multitude of effects on the neuroendocrine and autonomic nervous systems which, 
in turn, may predispose to myocardial ischemia and arrhythmias [Furukawa et al., 1989; Ironson 
et al., 1992]. Ironson et al. [1992] suggest that anger may be one of the most potent emotions in 
that it reduces ejection fraction in patients with a history of coronary artery disease setting up an 
arrhythmogenic situation. In this study, the lack of influence of anger may be a function of the 
length of time between its measurement and time of device therapy. Anger is an acute emotion 
with more immediate effects that may not have been captured in the measurement time points of 
this study. In addition, a portion of the subjects did not have a history of coronary artery disease 
as did all subjects in previous studies documenting the effects of anger [Furukawa et al., 1989; 
Ironson et al., 1992; Thomas et al., 1997]. 
Depression has been shown to be a very potent risk factor for arrhythmia and sudden cardiac 
death [Frasure-Smith et al., 1993; Frasure-Smith et al., 1995; Barefoot and Schroll, 1996; 
Thomas et al., 1997]. The lack of contribution of depressed mood to this arrhythmia events in 
this sample may be due to the low depressed mood scores in this sample, the measure of mood 
state versus clinical measurement of depression, and/or the hypothesized mechanisms through 
which depression exerts negative cardiac effects such as impaired serotonin levels and effects on 
platelets [Musselman et al., 1998]. Anxiety and tension, on the other hand, involves heightened 
sympathetic arousal and imbalances between the sympathetic and parasympathetic systems 
which mediates an arrhythmogenic environment [Goldberg et al., 1996]. Most studies of the 
effect of emotion on arrhythmia have been documented with acute, task-oriented provocations of 
emotions, and little is known about the more chronic effects of extended negative emotion, 
especially chronic anxiety. For a sustained arrhythmia to develop, an interaction is required 
between a trigger, substrate and other factors such as sympathetic and parasympathetic nervous 
system. The presence of ongoing chronic anxiety may heighten susceptibility to arrhythmia by 
sustained sympathetic stimulation or depressed vagal tone. Studies of the role of both acute and 
extended emotional distress in vulnerable patients, specific emotions and pathways are essential 
to better understand these mind-body interactions. 
Another possible explanation for the findings could be that the patients who experienced 
arrhythmia events perceived themselves as sicker and with worse prognosis that those who did 
not experience events regardless of similar ejection fraction and clinical features. The higher 
total mood disturbance in the arrhythmia event group may be a reflection of the reciprocal nature 
of perception rather than a causative factor in events. Given the high POMS scores and the low 
LVEF, the influence of the fatigue and vigor scores may have reflected the combined interaction 
of compromised cardiac status and emotional distress. The opposite direction of the likelihood 
between arrhythmia event and scores of fatigue (positive) and vigor (negative) would be 
expected in terms of their hypothesized effects. Nevertheless, the association of negative emotion 
and arrhythmia events in this study suggests that the nature of the relationship deserves further 
attention in both research and clinical practice.  
There are a number of important limitations to this study. The duration of follow-up was 
relatively brief and included new ICD patients. It is unknown whether prolonged mood 
disturbance continues to pose an ongoing risk of arrhythmia events and whether the findings are 
generalizable to long-term ICD patients. Multivariate analysis has shown a clear association 
between mood disturbance and arrhythmia events, but this technique does not prove cause and 
effect. It is possible that an uncontrolled co-morbid variable may have played an important role. 
Prospective controlled trials of psychological states and intervention after ICD implantation will 
be required to demonstrate that reduction in mood disturbance will have an antiarrhythmic effect. 
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